ImmuCell Corp (NASDAQ:ICCC)

7.36
Delayed Data
As of Feb 16
 +0.0495 / +0.68%
Today’s Change
5.00
Today|||52-Week Range
9.25
-16.27%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close7.31
Today’s open7.28
Day’s range7.28 - 7.37
Volume1,032
Average volume (3 months)12,286
Market cap$37.2M
Data as of 3:52pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-125.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+9.29%
P/E ratio736.0
Price/Sales4.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CRMDCorMedix Inc+0.01+1.06%
APVOAptevo Therapeutics ...-0.02-0.60%
BPTHBio Path Holdings In...-0.02-1.24%
CSBRChampions Oncology I...-0.04-1.13%
Data as of 8:00pm ET, 02/16/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$10.4M
Annual profit (last year)-$168.0K
Net profit margin-1.61%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts